|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,749 INR | +0.90% |
|
-0.14% | -3.98% |
| 03/05 | Procter & Gamble Health's Profit Declines in Fiscal Q3 | MT |
| 02/05 | Procter & Gamble Health Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 | CI |
Procter & Gamble Health Limited reported earnings results for the full year ended June 30, 2022. For the full year, the company reported sales was INR 11,144.1 million compared to INR 10,087.3 million a year ago. Revenue was INR 11,276 million compared to INR 10,268.3 million a year ago.
Net income was INR 1,925.2 million compared to INR 1,768 million a year ago. Basic earnings per share from continuing operations was INR 116 compared to INR 106.5 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -3.98% | 936M | |
| +22.69% | 43.81B | |
| +25.56% | 23.01B | |
| +18.96% | 15.27B | |
| +8.91% | 13.68B | |
| +42.72% | 11.96B | |
| -7.49% | 6.98B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +13.26% | 5.59B |
PROCTER & GAMBLE HEALTH LIMITED 